doi: 10.1038/s41598-023-42760-4, 18 ChenL.MinJ.WangF
Poly-agonists : Drugs combining GLP-1 with other hormones (GIP, glucagon, amylin) to potentially increase weight loss
The evidence for alcohol is the strongest, but if CNS-targeted GLP-1 compounds can be developed specifically for addiction, the mechanism may be general enough to work across multiple substance classes
Lipton, MD, Professor of Neurology and Director of the Montefiore Headache Center, Albert Einstein College of Medicine, commented, A significant proportion of migraine patients experience inadequate efficacy with currently available acute treatments, leading to even greater suffering, and an increased risk of worsening of migraine pain and attack frequency
while it is derived from HGH, its structure itself changes fairly much when one looks at hydrogen, nitrogen and oxygens different molecular behaviors
particularly low-volume rural and small hospitals may be unable to report on many of the included measures
